Dyslipidemia, Hypercholesterolemia, and Mixed Hyperlipidemia: What These Terms Actually Mean

Seeing "dyslipidemia," "mixed hyperlipidemia," or "hypercholesterolemia" on a lab report or diagnosis for the first time raises an obvious question: are these different names for the same underlying thing, or genuinely different conditions entirely? They are related but distinct, and knowing which one actually applies changes what the number on your lab report is telling you.

This guide sorts out the terminology, covers the less-common inherited types and what causes each one, and explains two specific results, high HDL and high non-HDL cholesterol, that confuse people in opposite directions.

Sorting Out the Terms

Dyslipidemia is the broadest term: any imbalance in blood lipids, whether levels are too high or too low. Hyperlipidemia is a specific type of dyslipidemia: elevated lipid levels, and it does not include low levels of anything. Hypercholesterolemia is narrower still: a type of hyperlipidemia limited to high LDL or total cholesterol, and it does not, by definition, include triglycerides.

The conditions page introduces these three terms briefly; this article goes deeper into what actually separates them.

Mixed hyperlipidemia describes a specific, common pattern within this hierarchy: both cholesterol and triglycerides are elevated at the same time, often alongside low HDL. It is not a separate disease so much as a description of which lipids are affected, and it shapes treatment differently than a cholesterol-only or triglyceride-only pattern would on its own.

Read More: Hyperlipidemia and High Cholesterol: Symptoms, Causes, Diagnosis, and Treatment

Primary vs. Secondary, and the Rare Inherited Types

Primary hyperlipidemia derives directly from a genetic disorder present from birth, even when it goes undetected until an adult lab result reveals it. The most common example is familial hypercholesterolemia, which affects roughly 1 in 250 people, causes very high LDL (often 190 mg/dL or higher) from childhood, and sharply raises early heart disease risk, so close relatives of anyone diagnosed should be tested too. Secondary hyperlipidemia develops later, driven by another condition or exposure entirely, such as diabetes, an underactive thyroid, kidney disease, certain medications, heavy alcohol use, or obesity. This distinction matters enormously for outlook, which the next section covers directly.

A small number of rare inherited forms fall under an older classification system, the Fredrickson types, numbered from I through V. Type I, sometimes called familial chylomicronemia, is extremely rare, affecting roughly 1 in a million people, and causes severe triglyceride elevation that responds poorly to typical triglyceride medications, requiring strict dietary fat restriction instead. A targeted medication, olezarsen (Tryngolza), was FDA-approved for this condition in late 2024.

Most people with a hyperlipidemia diagnosis do not have one of these rare subtypes, but the classification still shows up on genetic testing and specialist referrals for unusually severe or treatment-resistant cases.

When HDL or Non-HDL Cholesterol Comes Back High

HDL is often called the "good" cholesterol, which can make a high HDL result feel reassuring, but the reality is more complicated. Moderately elevated HDL is generally protective, but research shows extremely high HDL, above roughly 80 mg/dL, carries a paradoxical association with higher mortality rather than lower.

This unexpected finding prompted researchers to reconsider whether very high HDL always functions the way moderate HDL does. This does not mean high HDL is dangerous for most people, but it does mean "higher is always better" is not the correct way to think about this particular number.

Non-HDL cholesterol works quite differently: it is total cholesterol minus HDL, capturing LDL along with other cholesterol-carrying particles that LDL alone misses entirely. Multiple recent studies have found that non-HDL cholesterol predicts cardiovascular events better than LDL cholesterol alone.

Since non-HDL captures LDL plus VLDL and other triglyceride-carrying particles, it tends to tell a more complete story specifically when triglycerides run high, a case where LDL alone can understate the real picture. A high non-HDL result is worth taking seriously even when LDL specifically looks acceptable.

Does Hyperlipidemia Cause Symptoms?

Almost never on its own, in the vast majority of cases. The large majority of people with hyperlipidemia have no symptoms at all whatsoever, which is exactly why routine screening matters more than watching for warning signs. In rare cases of severe, usually inherited hyperlipidemia, fatty deposits can appear under the skin, called xanthomas, most often on the eyelids, palms, or tendons, but these are the exception rather than something most people should expect to notice.

The relationship with blood pressure is real but indirect, not a simple, direct cause-and-effect. Prospective research has found that abnormal lipid levels genuinely raise the risk of later developing high blood pressure, likely through effects on blood vessel lining and arterial stiffness rather than through blood pressure directly.

The two conditions also share enough risk factors (like weight, diet, and inactivity) that they frequently show up in the same person regardless of any direct mechanism.

What Happens Next

Treatment depends heavily on which of these specific terms actually applies and precisely why. Mixed hyperlipidemia often needs a different approach than a cholesterol-only or triglyceride-only pattern, since a single medication rarely addresses both elevated markers equally well.

• Atorvastatin, a statin, is the typical starting point when cholesterol specifically is elevated

• Fenofibrate, used mainly when triglycerides are very high (generally 500 mg/dL or above) to lower pancreatitis risk, since statins remain the first choice for reducing heart risk even when triglycerides are moderately elevated

The primary-versus-secondary distinction matters just as much for the long-term outlook overall. Secondary hyperlipidemia is often reversible or substantially improved by treating the underlying cause: correcting an underactive thyroid, improving diabetes control, or stopping a contributing medication can normalize lipid levels without lipid-specific treatment. Primary genetic hyperlipidemia does not go away in the same sense, but it remains very manageable with ongoing treatment.

Where to Start

If a diagnosis or lab report uses one of these specific terms and it is genuinely not clear which pattern applies, ask specifically which lipid markers are elevated, cholesterol, triglycerides, or both, and whether your clinician suspects a primary or secondary cause. That single distinction shapes the next several steps far more than the specific label on the diagnosis does.

If a secondary cause is suspected, ask what additional testing might identify it, since treating an underlying thyroid or blood sugar problem can sometimes resolve the lipid issue entirely without separate medication. The conditions page covers the full diagnostic picture, including how to read lipid panels overall.

Read More: Hyperlipidemia and High Cholesterol: Symptoms, Causes, Diagnosis, and Treatment